Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

OHSU researchers found that combining venetoclax with breast cancer drug palbociclib strongly improves AML treatment by ...

A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but ...

For more than 25 years, humans have lived and worked continuously aboard the International Space Station, conducting research ...

IT’S TIME FOR THE KCRA 3 ANNUAL BLOOD DRIVE FOR LIFE. THIS IS AN OPPORTUNITY TO DONATE BLOOD AND HELP SAVE A LIFE. MAYBE MORE ...

"They did the blood tests, and they came back ‘a bit spicy’—the doctor’s words," mom Elle Rugari told Newsweek.

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

Tatiana Schlossberg faced down cancer with raw honesty until it claimed her life early Tuesday morning, December 30, 2025, at ...

Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its ...

The 'Growler' signal-jamming jet that helped capture Nicolás Maduro Béla Fleck withdraws from Kennedy Center concerts after ...